Expression of cell cycle markers in colorectal carcinoma: Superiority of cyclin a as an indicator of poor prognosis

International Journal of Cancer

Volumn 84, Issue 3, 1999, Pages 225-233

  Handa, Kazuhiro ^a   Yamakawa, Mitsunori ^b   Takeda, Hiroaki ^a   Kimura, Seishi ^a   Takahashi, Tsuneo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; HISTONE H3; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; TUMOR GROWTH;

ADULT; AGED; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; CYCLIN A; FEMALE; HISTONES; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE;

EID: 0033038931     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990621)84:3<225::AID-IJC5>3.0.CO;2-A     Document Type: Article

References (25)

1. ARBER, N., HIBSHOOSH, H., MOSS, S.F., SUTTER, T., ZHANG, Y., BEGG, M., WANG, S., WEINSTEIN, I.B. and HOLT, P.R., Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 110, 669-674 (1996).
2. BARTKOVA, J., LUKAS, J., STRAUSS, M. and BARTEK, J., The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int. J. Cancer, 58, 568-573 (1994).
3. CATTORETTI, G., BECKER, M.H., KEY, G., DUCHROW, M., SCHLUTER, C., GALLE, J. and GERDES, J., Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol., 168, 357-363 (1992).
4. CHAO, Y., SHIH, Y.L., CHIU, J.H., CHAU, G.Y., LUI, W.Y., YANG, W.K., LEE, S.D. and HUANG, T.S., Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res., 58, 985-990 (1998).
5. CHOU, M.Y., CHANG, A.L., MCBRIDE, J., DONOFF, B., GALLAGHER, G.T. and WONG, D.T., A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization. Amer. J. Pathol., 136, 729-733 (1990).
6. CORDON-CARDO, C., Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Amer. J. Pathol., 147, 545-560 (1995).
7. GERDES, J., LEMKE, H., BAISCH, H., WACKER, H.H., SCHWAB, U. and STEIN, H., Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133, 1710-1715 (1984).
8. GIRARD, F., STRAUSFELD, U., FERNANDEZ, A. and LAMB, N.J., Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell, 67, 1169-1179 (1991).
9. GOWN, A.M., JIANG, J.J., MATLES, H., SKELLY, M., GOODPASTER, T., CASS, L., RESHATOF, M., SPAULDING, D. and COLTRERA, M.D., Validation of the S-phase specificity of histone (H3) in situ hybridization in normal and malignant cells. J. Histochem. Cytochem., 44, 221-226 (1996).
10. HUNTER, T. and PINES, J., Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell, 79, 573-582 (1994).
11. JARES, P., FERNANDEZ, P.L., CAMPO, E., NADAL, A., BOSCH, F., AIZA, G., NAYACH, I., TRASERRA, J. and CARDESA, A., PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54, 4813-4817 (1994).
12. JASS, J.R. and SOBIN, L.H., World Health Organization. International classification of tumors: histological typing of intestinal tumors, Springer, New York (1989).
13. KING, R.J., COFFER, A.I., GILBERT, J., LEWIS, K., NASH, R., MILLIS, R., RAJU, S. and TAYLOR, R.W., Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium. Cancer Res., 45, 5728-5733 (1985).
14. KUBOTA, Y., PETRAS, R.E., EASLEY, K.A., BAUER, T.W., TUBBS, R.R. and FAZIO, V.W., Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer, 70, 2602-2609 (1992).
15. LEACH, F.S., ELLEDGE, S.J., SHERR, C.J., WILLSON, J.K., MARKOWITZ, S., KINZLER, K.W. and VOGELSTEIN, B., Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53, 1986-1989 (1993).
16. MAEDA, K., CHUNG, Y.S., KANG, S.M., OGAWA, M., ONODA, N., NAKATA, B., NISHIGUCHI, Y., IKEHARA, T., OKUNO, M. and SOWA, M., Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma. Int. J. Cancer, 74, 310-315 (1997).
17. MATE, J.L., ARIZA, A., ARACIL, C.. LOPEZ, D., ISAMAT, M., PEREZ-PITEIRA, J. and NAVAS-PALACIOS, J.J., Cyclin D1 overexpression in non-small cell lung carcinoma: correlalion with Ki67 labelling index and poor cytoplasmic differentiation. J. Pathol., 180, 395-399 (1996).
18. NAGAO, T., ISHIDA, Y. and KONDO, Y., Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers. Mod. Pathol., 9, 99-104 (1996).
19. PAGANO, M., PEPPERKOK, R., VERDE, F., ANSORGE, W. and DRAETTA, G., Cyclin A is required at two points in the human cell cycle. EMBO J., 11, 961-971 (1992).
20. SAHIN, A.A., RO, J.Y., BROWN, R.W., ORDONEZ, N.G., CLEARY, K.R., EL-NAGGAR, A.K., WILSON, P. and AYALA, A.G., Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas. Mod. Pathol., 7, 17-22 (1994).
21. SHI, S.R., KEY, M.E. and KALRA, K.L., Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven healing of tissue sections. J. Histochem. Cytochem., 39, 741-748 (1991).
22. SOBIN, L.H. and WITTEKIND, C. (eds.), TNM classification of malignant tumors (5th ed.), John Wiley, New York (1997).
23. SUZUKI, H., MATSUMOTO, K. and TERABE, M., Ki-67 antibody labeling index in colorectal carcinoma. J. Clin. Gastmenterol., 15, 317-320 (1992).
24. VOLM, M., KOOMAGI, R., MATTERN, J. and STAMMLER, G., Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Brit. J. Cancer, 75, 1774-1778 (1997).
25. WANG, A., YOSHIMI, N., SUZUI, M., YAMAUCHI, A., TARAO, M. and MORI, H., Different expression patterns of cyclins A, D1 and E in human colorectal cancer. J. Cancer Res. Clin. Oncol., 122, 122-126 (1996).